What is iBeat?
iBeat operates at the intersection of consumer electronics and life-saving medical technology. Its flagship offering, the iBeat Heart Watch, serves as a continuous, 24-7 monitoring solution designed to detect cardiac anomalies in real-time. By providing an immediate alert system for users, their families, and emergency responders, the company addresses critical gaps in personal safety. While currently positioned as a consumer wearable, iBeat is actively pursuing FDA clearance to transition its device into a formal medical instrument, a move that would significantly expand its addressable market and clinical utility within the digital health ecosystem.
How much funding has iBeat raised?
iBeat has raised a total of $12.7M across 3 funding rounds:
Angel/Seed
$10M
Other Financing Round
$2.5M
Debt
$150K
Angel/Seed (2018): $10M with participation from 8VC, Kairos, City Light Capital, Subtraction Capital, Maveron, ChinaRock Capital Management, and Plug and Play Ventures
Other Financing Round (2018): $2.5M led by Transamerica Ventures and Scor
Debt (2020): $150K supported by PPP
Key Investors in iBeat
8VC
A leading technology investment firm managing significant committed capital, focusing on smart enterprise platforms across healthcare, financial services, and Bio-IT sectors.
Maveron
A consumer-focused venture capital firm that partners with innovative entrepreneurs to transform consumer experiences and industries through technological disruption.
Transamerica Ventures
A corporate venture arm specializing in high-growth technology companies within the Insurtech, Fintech, and Digital Health verticals.
What's next for iBeat?
The recent capital injection positions iBeat to accelerate its regulatory roadmap and scale its operational infrastructure. As the company moves toward formal medical device certification, the focus will likely shift toward deepening its integration with healthcare providers and emergency services. By leveraging its existing technological moats and the support of its diverse investor base, iBeat is well-positioned to transition from a consumer-focused startup to a pivotal player in the enterprise-level health-tech landscape, potentially setting new standards for proactive, data-driven cardiac care.
See full iBeat company page
